SLP实时信号 | 通过Getagraph.com最大化利润

出售 106498 min ago

@ $40.16

发出时间: 15 Feb 2024 @ 00:36

回报率: 11.29%

上一信号: Feb 13 - 22:30

上一信号: 购买

回报率: -0.88 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	76 473.00
平均成交量	109 138
市值	893.13M
EPS	$0 ( 2024-04-03 )
下一个收益日期	( $0.180 ) 2024-07-04
Last Dividend	$0.0600 ( 2023-10-27 )
Next Dividend	$0 ( N/A )
P/E	85.94
ATR14	$0.0440 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Woltosz Walter S	Sell	19 410	Common Stock
2024-04-01	Woltosz Walter S	Sell	590	Common Stock
2024-03-28	Szot Daniel	Buy	30 000	Stock Options (Right to Buy)
2024-03-01	Woltosz Walter S	Sell	17 600	Common Stock
2024-03-01	Woltosz Walter S	Sell	2 400	Common Stock

INSIDER POWER
-41.28
Last 97 transactions
Buy: 243 785 \| Sell: 655 613

音量相关性

長: 0.20 (neutral)

短: -0.48 (neutral)

Signal:(42.463) Neutral

Simulations Plus Inc 相关性

10 最正相关
EMBCV	0.822

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Simulations Plus Inc 相关性 - 货币/商品

0.54
( weak )

0.25
( neutral )

0.00
( neutral )

0.70
( moderate )

-0.26
( neutral )

-0.81
( strong negative )

Simulations Plus Inc 财务报表

Annual	2023
营收:	$59.58M
毛利润:	$47.95M (80.48 %)
EPS:	$0.500

FY	2023
营收:	$59.58M
毛利润:	$47.95M (80.48 %)
EPS:	$0.500

FY	2022
营收:	$53.91M
毛利润:	$43.08M (79.92 %)
EPS:	$0.620

FY	2021
营收:	$46.47M
毛利润:	$35.87M (77.19 %)
EPS:	$0.490

Financial Reports:

No articles found.

Simulations Plus Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.0600 (N/A)	$0.0600 (N/A)	$0.0600 (N/A)	$0.0600 (N/A)	$0.0600 (N/A)	$0.0600 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Simulations Plus Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.47 - Decrease likely (30.59%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0500	2012-02-16
Last Dividend	$0.0600	2023-10-27
Next Dividend	$0	N/A
Payout Date	2023-11-06
Next Payout Date	N/A
# dividends	48	--
Total Paid Out	$2.69	--
Avg. Dividend % Per Year	0.37%	--
Score	4.4	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.47
Div. Directional Score	7.58	--

Next Divdend (Est)
(2024-07-09)

$0.0610 Estimate 39.78 %

Dividend Stability

0.80 Good

Dividend Score

4.40

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0.340	11.30%
2013	$0.100	2.29%
2014	$0.200	3.92%
2015	$0.200	2.95%
2016	$0.200	2.07%
2017	$0.210	2.33%
2018	$0.240	1.53%
2019	$0.240	1.21%
2020	$0.240	0.84%
2021	$0.240	0.32%
2022	$0.240	0.48%
2023	$0.240	0.65%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.163	1.500	6.75	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0542	1.200	8.19	9.83	[0 - 0.3]
returnOnEquityTTM	0.0611	1.500	-0.433	-0.649	[0.1 - 1]
payoutRatioTTM	0.455	-1.000	5.45	-5.45	[0 - 1]
currentRatioTTM	8.81	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	8.55	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.55	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00532	-1.500	9.91	-10.00	[0 - 0.6]
interestCoverageTTM	6.31	1.000	8.77	8.77	[3 - 30]
operatingCashFlowPerShareTTM	0.880	2.00	9.71	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.639	2.00	9.68	10.00	[0 - 20]
debtEquityRatioTTM	0.00583	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.751	1.000	0.810	0.810	[0.2 - 0.8]
operatingProfitMarginTTM	0.171	1.000	8.57	8.57	[0.1 - 0.6]
cashFlowToDebtRatioTTM	17.03	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.333	0.800	-1.111	-0.889	[0.5 - 2]
Total Score				11.69

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	84.89	1.000	1.526	0	[1 - 100]
returnOnEquityTTM	0.0611	2.50	-0.278	-0.649	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.639	2.00	9.79	10.00	[0 - 30]
dividendYielPercentageTTM	0.537	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.880	2.00	9.71	10.00	[0 - 30]
payoutRatioTTM	0.455	1.500	5.45	-5.45	[0 - 1]
pegRatioTTM	-4.39	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.272	1.000	5.70	0	[0.1 - 0.5]
Total Score				3.47

Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.